WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Asthma+Allergic Rhinitis, Patient Information Demographics 39 YOM, Asthma Pathophysiology Respiratory acidosis, Allergic Rhinitis Symptoms Frequent Sneezing, Asthma Treatment Options Drugs used in Asthma, Late-Phase Response Onset 4+ hours, Asthma Symptoms Shortness of Breath, Patient Information Demographics No MD care until 19 YO, Non-allergic include Acute and chronic infections, Pre-formed IgE (allergen-specific) triggers mast cell activation; Mediator Release - Histamine Reaction Can occur within seconds-minutes of exposure; Severity ranges from irritating to fatal, Patient Information Triggers Temperate Change, Late-Phase Response Predominant Mediator Types Cysteinyl leukotrienes, Pre-formed IgE (allergen-specific) triggers mast cell activation; Mediator Release - Histamine Release Immediately Causes Vasodilation, Allergic Rhinitis Classifications Mild, Effective in rhinorrhea, congestion, sneezing, nasal itching ocular symptoms Onset 12 hours, Non-allergic include Non-infective (vaso-motor, drugs irritants, hormonal, idiopathic), Local Cromone (Mast Cell Stabalizer) Use Effective in nasal itching, rhinorrhea, sneezing, allergic stuffy nose, Moderate Severity - sleep disturbance - impairment of daily activities, sport & leisure - impairment of work & school - troublesome symptoms, Pre-formed IgE (allergen-specific) triggers mast cell activation; Mediator Release - Histamine Release Immediately Causes Sensory nerve activation, Allergic Rhinitis Classifications Moderate, Patient Information Demographics Unable to work due to uncontrolled asthma and rhinitis